Trials / Completed
CompletedNCT01206153
Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic Patients
Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic Patients: a Double Blind, Placebo-controlled Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- Central South University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Antipsychotics such as risperidone could induce amenorrhea in schizophrenic patients. The investigators conducted a randomized, placebo-controlled study to test the efficacy of metformin for antipsychotic induced amenorrhea in schizophrenia patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | metformin |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2010-01-01
- Completion
- 2010-03-01
- First posted
- 2010-09-21
- Last updated
- 2010-09-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01206153. Inclusion in this directory is not an endorsement.